Insights From the Experts at Teiko

In this webinar, we’ll dive into the game-changing advantages of fixed sample processing in spectral flow cytometry. We compared live versus fixed samples across 36 phenotypic populations and 62 state marker subtypes, revealing: 0.97 correlation in population frequencies and 0.91 correlation in state marker-positive subset frequencies

In this “essentials” series, Ramji Srinivasan, CEO and cofounder, explains the physical differences between spectral flow cytometry and conventional flow cytometry.

Understand a new method of pricing in cytometry services, “price per service.” CEO and cofounder, Ramji Srinivasan, walks you through this definition and how to analyze different cytometry options available to you.

In this webinar, Ramji Srinivasan, CEO and Cofounder, analyzes three published spectral flow reports and runs a hypothetical eight-marker panel against them. He compares the differences between the outputs of each panel.

In this webinar, Ramji Srinivasan presents precision and stability data for our 25-marker spectral flow cytometry panel, designed for immune profiling of PBMCs from healthy human samples.

William Chronister will walk you through each analysis tier — Base, Core, and Premier — using our TokuProfile web application.

Lee Leavitt, Senior Bioinformatics Engineer, demonstrates our new web based solution for ordering and tracking specimen collection kits.

In this live webinar, we’ll guide you through a full demo of the TokuKit, covering every step from blood draw to kit processing and storage at -80°C.

In this live webinar, Carlos Medina, Director of Product Management, and Will Chronister, Senior Computational Scientist, demonstrate how to use the the newly redesigned TokuProfile Web to answer key questions using real-world customer data.

In this live webinar, Ramji Srinivasan, cofounder and CEO of Teiko Bio, will walk through the precision and stability data for our mass cytometry assay for pan-immune profiling of PBMCs isolated from healthy human clinical samples.

Dr. Jolien Sweere discusses data from a technical validation experiment performed by Teiko Bio showing how mass cytometry immune profiling data from whole blood compares to data from PBMCs.

Ramji Srinivasan, cofounder and CEO of Teiko Bio, shares original research on blood-based biomarkers of immune-related adverse events in metastatic melanoma performed by Teiko scientists in collaboration with Dr. Siwen Hu-Lieskovan of Huntsman Cancer Institute.

Dr. Jolien Sweere walks us through scientific publications showing that immune responses outside the tumor are necessary for effective immunotherapy.

Where do T cells get activated after cancer immunotherapy? Matthew Spitzer, PhD, reviews current literature and his lab’s recent Cell publication in this educational webinar.